Listed pharmaceutical companies’ sales management expenses about to go under 30%

This year, the average sales management expense ratios to sales decreased to less than 30% among listed pharmaceutical in the KOSPI and the same ratio of KOSDAQ listed pharmaceutical companies has still remained above 30% in the 3^rd quarter. On the other hand, the amount of sales management expenses of the KOSPI listed pharmaceuticals was narrowly increased and the one of the KOSDAQ was decreas...